Ocugen (OCGN) Capital Expenditures Growth (1y) (2015 - 2026)
Ocugen (OCGN) Capital Expenditures Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | -62.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.50% |
| Dec 31, 2025 | 1,176.92% |
| Sep 30, 2025 | -101.28% |
| Jun 30, 2025 | 102.04% |
| Mar 31, 2025 | -99.32% |
| Dec 31, 2024 | 100.23% |
| Sep 30, 2024 | -38.91% |
| Jun 30, 2024 | -305.46% |
| Mar 31, 2024 | 45.91% |
| Dec 31, 2023 | -1,639.06% |
| Sep 30, 2023 | 1,529.33% |
| Jun 30, 2023 | -24.96% |
| Mar 31, 2023 | 622.87% |
| Dec 31, 2022 | 56.22% |
| Sep 30, 2022 | -260.54% |
| Jun 30, 2022 | 419.39% |
| Mar 31, 2022 | -14.56% |
| Dec 31, 2021 | -338.11% |
| Sep 30, 2021 | 755.88% |
| Jun 30, 2021 | 1,484.21% |